FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Theresa Mo

Research Profile

Disorders

HIV Infections

Living Beings

HIV-1

Concepts & Ideas

Chemicals & Drugs

Physiology

Procedures

Geographic Areas

British Columbia

Co-author Network

Publications

TOP 3
Luke C Swenson; Hernan Valdez; Jayvant Heera; Theresa Mo; Art F Y Poon; Doug Chapman; James Demarest; Winnie W Y Dong; Suzanne Ellery; P Richard Harrigan
Use of Cellular HIV DNA to Predict Virologic Response to Maraviroc: Performance of Population-Based and Deep Sequencing.
Rachel A McGovern; Theresa Mo; Simon Portsmouth; Alexander Thielen; Hernan Valdez; Conan K Woods; Xiaoyin Zhong; Chanson J Brumme; Douglass Chapman; Winnie Dong; Jayvant Heera; Ian James; Marilyn Lewis; P Richard Harrigan
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.
David J H F Knapp; Theresa Mo; Brian Wynhoven; Zabrina L Brumme; Winnie W Y Dong; P Richard Harrigan; Sheng Yuan Huang; Chanson J Brumme
Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Theresa Mo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Luke C Swenson; Hernan Valdez; Jayvant Heera; Theresa Mo; Art F Y Poon; Doug Chapman; James Demarest; Winnie W Y Dong; Suzanne Ellery; P Richard Harrigan
Use of Cellular HIV DNA to Predict Virologic Response to Maraviroc: Performance of Population-Based and Deep Sequencing.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(11):1659-66.
2012: Rachel A McGovern; Theresa Mo; Simon Portsmouth; Alexander Thielen; Hernan Valdez; Conan K Woods; Xiaoyin Zhong; Chanson J Brumme; Douglass Chapman; Winnie Dong; Jayvant Heera; Ian James; Marilyn Lewis; P Richard Harrigan
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.
Journal of acquired immune deficiency syndromes (1999) 2012;61(3):279-86.
2012: David J H F Knapp; Theresa Mo; Brian Wynhoven; Zabrina L Brumme; Winnie W Y Dong; P Richard Harrigan; Sheng Yuan Huang; Chanson J Brumme
Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(11):1652-9.
2011: Luke C Swenson; Alexander Thielen; Hernan Valdez; Conan K Woods; Xiaoyin Zhong; Jayvant Heera; Ian James; Mark A Jensen; David J H F Knapp; Marilyn Lewis; Theresa Mo; Simon Portsmouth; Douglass Chapman; Winnie W Y Dong; P Richard Harrigan
Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(7):732-42.
2011: Luke C Swenson; Theresa Mo; Winnie W Y Dong; Xiaoyin Zhong; Conan K Woods; Mark A Jensen; Alexander Thielen; Douglass Chapman; Marilyn Lewis; Ian James; Jayvant Heera; Hernan Valdez; P Richard Harrigan
Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients.
The Journal of infectious diseases 2011;203(2):237-45.
2011: Luke C Swenson; Graham Pollock; Brian Wynhoven; Theresa Mo; Winnie Dong; Hogg Robert; Julio S G Montaner; P Richard Harrigan
"Dynamic range" of inferred phenotypic HIV drug resistance values in clinical practice.
PloS one 2011;6(2):e17402.
2010: Rachel A McGovern; Alexander Thielen; Theresa Mo; Winnie Dong; Conan K Woods; Douglass Chapman; Marilyn Lewis; Ian James; Jayvant Heera; Hernan Valdez; P Richard Harrigan
Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
AIDS (London, England) 2010;24(16):2517-25.
2007: P Richard Harrigan; Theresa Mo; Jennifer Hirsch; Zabrina L Brumme; Paula McKenna; Lee Bacheler
A 21-base pair insertion/duplication at codon 69 of the HIV type 1 reverse transcriptase in a patient undergoing multiple nucleoside therapy.
AIDS research and human retroviruses 2007;23(7):895-9.
2007: Mona R Loutfy; Janet Raboud; Julio S G Montaner; Tony Antoniou; Brian Wynhoven; Fiona Smaill; Danielle Rouleau; J Gill; Walter F Schlech; Zabrina L Brumme; Theresa Mo; Kevin Gough; Anita Rachlis; P R Harrigan; Sharon L Walmsley
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide.
Antiviral research 2007;75(1):58-63.
2007: Zabrina L Brumme; Chanson J Brumme; Celia Chui; Theresa Mo; Brian Wynhoven; Conan K Woods; Bethany M Henrick; Hogg Robert; Julio S G Montaner; P Richard Harrigan
Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.
The Journal of infectious diseases 2007;195(11):1694-704.
2006: Celia Chui; Peter K Cheung; Chanson J Brumme; Theresa Mo; Zabrina L Brumme; Julio S G Montaner; andrew badley; P Richard Harrigan
HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy.
AIDS research and human retroviruses 2006;22(7):615-8.
2006: Jin K Ho; P Richard Harrigan; Christopher H Sherlock; Urs P Steinbrecher; Siegfried R Erb; Theresa Mo; Stephen W Chung; Andrzej K Buczkowski; Pongphob Intaraprasong; Charles H Scudamore; Eric M Yoshida
Utilization of a liver allograft from a hepatitis B surface antigen positive donor.
Transplantation 2006;81(1):129-31.
2005: Evan Wood; Hogg Robert; Benita Yip; Winnie W Y Dong; Brian Wynhoven; Theresa Mo; Chanson J Brumme; Julio S G Montaner; P Richard Harrigan
Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.
AIDS (London, England) 2005;19(11):1189-95.
2005: P Richard Harrigan; Theresa Mo; Brian Wynhoven; Jennifer Hirsch; Zabrina L Brumme; Paula McKenna; Theresa Pattery; Johan Vingerhoets; Lee Bacheler
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.
AIDS (London, England) 2005;19(6):549-54.
2005: P Richard Harrigan; Hogg Robert; Winnie W Y Dong; Benita Yip; Brian Wynhoven; Justin Woodward; Chanson J Brumme; Zabrina L Brumme; Theresa Mo; Christopher S Alexander; Julio S G Montaner
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.
The Journal of infectious diseases 2005;191(3):339-47.
2003: Zabrina L Brumme; Keith J Chan; Winnie W Y Dong; Brian Wynhoven; Theresa Mo; Hogg Robert; Julio S G Montaner; Michael V O'Shaughnessy; P Richard Harrigan
Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy.
Antiviral therapy 2003;8(2):91-6.
2002: Zabrina L Brumme; Keith J Chan; Winnie W Y Dong; Theresa Mo; Brian Wynhoven; Hogg Robert; Julio S G Montaner; Michael V O'Shaughnessy; P Richard Harrigan
No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
AIDS (London, England) 2002;16(14):1929-33.
2002: Christopher S Alexander; Valentina Montessori; Brian Wynhoven; Winnie Dong; Keith Chan; Michael V O'Shaughnessy; Theresa Mo; Magda Piaseczny; Julio S G Montaner; P Richard Harrigan
Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British Columbia.
Antiviral therapy 2002;7(1):31-5.
2001: Christopher S Alexander; Winnie Dong; Keith Chan; Natalie Jahnke; Michael V O'Shaughnessy; Theresa Mo; M A Piaseczny; Julio S G Montaner; P Richard Harrigan
HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.
AIDS (London, England) 2001;15(5):601-7.
2000: Julio S G Montaner; Theresa Mo; Janet Raboud; Sandra Rae; Christopher S Alexander; Carlos Zala; Danielle Rouleau; P Richard Harrigan
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine.
The Journal of infectious diseases 2000;181(2):729-32.
1999: Christopher S Alexander; Winnie Dong; Martin T Schechter; Michael V O'Shaughnessy; Steffanie A Strathdee; Theresa Mo; Julio S G Montaner; P Richard Harrigan
Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users.
AIDS (London, England) 1999;13(8):981-5.